Alfasigma S.p.A.   Report issue

For profit Phase 3 Phase 4
Founded: MIlan Italy (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2015
NCT02512601
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

ALFASIGMA | Alfasigma S.p.A. | Bama GeVe, S.L.U. | Clinedem